HomepageABCL • NASDAQ
add
AbCellera Biologics Inc
Vorige slotkoers
$ 2,37
Dag-range
$ 2,38 - $ 2,49
Jaar-range
$ 1,89 - $ 3,76
Beurswaarde
728,30 mln. USD
Gem. volume
3,98 mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 4,24 mln. | -57,45% |
Bedrijfskosten | 24,40 mln. | -4,55% |
Netto inkomsten | -45,62 mln. | -12,34% |
Netto winstmarge | -1,08K | -164,04% |
Winst per aandeel | -0,15 | -7,14% |
EBITDA | -57,33 mln. | -14,54% |
Effectief belastingtarief | 13,90% | — |
Balans
Totale activa
Totale passiva
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 605,27 mln. | -13,29% |
Totale activa | 1,34 mld. | -8,13% |
Totale passiva | 321,23 mln. | -3,59% |
Totaal aandelenvermogen | 1,02 mld. | — |
Uitstaande aandelen | 298,48 mln. | — |
Koers-boekwaardeverhouding | 0,69 | — |
Rendement op activa | -11,58% | — |
Rendement op kapitaal | -14,16% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -45,62 mln. | -12,34% |
Operationele kasstroom | -11,55 mln. | 72,30% |
Kasstroom uit beleggingen | 7,94 mln. | -73,47% |
Kasstroom uit financiering | 5,97 mln. | 110,88% |
Nettomutatie in liquide middelen | 2,94 mln. | 130,17% |
Vrije kasstroom | -63,60 mln. | -21,59% |
Over
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Opgericht
2012
Hoofdvestiging
Website
Werknemers
596
